Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


Product Development Plan


All APR products and projects are based on a solid set of scientific data and/or proven technologies but in addition, they are also complemented, supported and maximized by an integrated strategic marketing model.


We define and coordinate the value chain from R&D and technology investments to the final consumer targets in order to deliver competitive products for our healthcare partners as well as effective added value products for patients and consumers.


We focus on strategic product planning: we internally analyze markets, trends and brands in order to identify new product /project opportunities, we identify the best development path for any product/project and we execute and control all the phases in order to deliver to our partners validated products; we finally support our partners and customers during all the launch phases and the commercial lifecycle with an integrated marketing plan.





Search results